Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 70, Issue 9, Pages 1677-1683Publisher
B M J PUBLISHING GROUP
DOI: 10.1136/ard.2010.140194
Keywords
-
Categories
Funding
- Fundacion Marques de Valdecilla
- Fondo de Investigacion Sanitaria [PI050475, PI080098]
- Fundacion Mutua Madrilena
- Fundacion Marques de Valdecilla-IFIMAV
- Schering-Plough, Spain
Ask authors/readers for more resources
Objective To investigate the expression and function of the Toll-like receptor (TLR) family in peripheral blood mononuclear cells (PBMCs) of patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). Methods The authors analysed 70 patients with PMR, 20 with GCA, and 24 healthy controls (HC). TLR expression was assessed by flow cytometry. TLR function was assessed by stimulating PBMCs with specific ligands. Results A significantly increased expression of TLR7 in PBMCs of patients with active disease compared with HC was found. Despite increased expression of TLR7, circulating monocytes from patients showed a significantly lower in vitro response to TLR7 agonists. No amino acid substitutions predicted to be functionally damaging were found in TLR7. A normal response to specific TLR7 agonists in patients in complete remission eliminated a genetic defect. TLR expression and function were also affected to some degree in other diseases characterised by a strong acute phase response. Conclusion These data suggest activation of TLR7 during the active phase of PMR and GCA which resolves with complete disease remission. Whether this finding is the consequence of the marked inflammatory process in these disorders or activation by natural ligands remains to be explored.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available